Medicare Enrolled

Dr. Sana Qureshi, MD

Ophthalmology · Boston, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
243 CHARLES ST, Boston, MA 02114
6175734443
In practice since 2017 (9 years)
NPI: 1023541729 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Qureshi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Qureshi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Qureshi

Dr. Sana Qureshi is an ophthalmology specialist in Boston, MA, with 9 years of NPI registration. Based on federal Medicare data, Dr. Qureshi performed 707 Medicare services across 416 unique beneficiaries.

Between the years covered by Open Payments, Dr. Qureshi received a total of $7,617 from 21 pharmaceutical and/or device companies across 106 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Qureshi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice ▲ 707 Medicare services $7,617 industry payments

Medicare Practice Summary

Medicare Utilization ↗
707
Medicare services
Bottom 28% in MA for ophthalmology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
416
Unique beneficiaries
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~79 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
232 $74 $125
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
109 $25 $265
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
77 $100 $176
CT scan of cornea
A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye.
74 $29 $250
Tear duct plug insertion
A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface.
66 $151 $576
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
61 $401 $5,000
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
36 $107 $220
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
21 $89 $150
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
20 $7 $125
Slit lamp examination of the eye
This procedure uses a specialized microscope to examine the front portion of the eye.
11 $33 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.6% high complexity
13.3% medium
78.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$7,617
Total received (2021-2024)
Avg $1,904/year across 4 years
Top 14% in MA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
106
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,879 (64.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,737 (35.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,607
2023
$869
2022
$3,305
2021
$1,836

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb Americas Inc.
$527
Dompe US, Inc.
$304
Glaukos Corporation
$191
Oyster Point Pharma, Inc.
$167
Mallinckrodt Hospital Products Inc.
$142
BIOTISSUE HOLDINGS INC.
$77
Tarsus Pharmaceuticals, Inc.
$52
Amgen Inc.
$48
Sight Sciences, Inc.
$28
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Johnson & Johnson Surgical Vision, Inc.
$18
ABBVIE INC.
$17
ANI Pharmaceuticals, Inc.
$15
Top 3 companies account for 63.6% of 2024 payments
All-time payments by company (2021-2024) ›
Intuitive Surgical, Inc.
$4,699
Bausch & Lomb Americas Inc.
$621
Dompe US, Inc.
$510
Johnson & Johnson Surgical Vision, Inc.
$389
Mallinckrodt Hospital Products Inc.
$337
Oyster Point Pharma, Inc.
$251
Glaukos Corporation
$191
ANI Pharmaceuticals, Inc.
$132
BIOTISSUE HOLDINGS INC.
$77
Novartis Pharmaceuticals Corporation
$71
Eyevance Pharmaceuticals LLC
$58
Tarsus Pharmaceuticals, Inc.
$52
Amgen Inc.
$48
Exeltis, USA Inc.
$37
Sight Sciences, Inc.
$28
RxSight Inc
$23
Santen Inc.
$21
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
EYEVANCE PHARMACEUTICALS LLC
$18
Travere Therapeutics, Inc.
$17
ABBVIE INC.
$17
Top 3 companies account for 76.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Catalys System · Cequa · Cholbam · DAVINCI XI · DURYSTA · Da Vinci Surgical System · Flarex · MIEBO · OMNI SURGICAL SYSTEM · OXERVATE · PURIFIED CORTROPHIN GEL · RXSIGHT CONTACT LENS · TECNIS IOL · TEPEZZA · TYRVAYA · Tecnis IOL · Tecnis Simplicity · VYZULTA · Verkazia · XDEMVY · XIIDRA · enVista Aspire IOL · enVista MX60 IOL · iDose
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware.

Looking for an ophthalmology specialist in Boston?
Compare ophthalmologists in the Boston area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
518
Per 100K population
66.2
County median income
$92,859
Nearest hospital
MASSACHUSETTS GENERAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Qureshi is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 14% of MA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Qureshi experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Qureshi performed 232 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Qureshi receive payments from pharmaceutical companies?
Yes. Dr. Qureshi received a total of $7,617 from 21 companies across 106 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Qureshi's costs compare to other ophthalmologists in Boston?
Dr. Qureshi's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Qureshi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →